DeepMind spin-off steps up efforts to use AI to create new drugs
Alphabet-owned Isomorphic Labs is ramping up operations by poaching pharma talent and opening a new office as the artificial intelligence drug discovery startup nears closing its first commercial deal. The UK-registered group spun off from sister company DeepMind, Google’s AI unit, in November last year to focus on using AI technology to create new drugs …
DeepMind spin-off steps up efforts to use AI to create new drugs Read More »